TB patients may soon ditch clinic visits by recording pill-taking on their phones

NCT ID NCT06574529

Completed Knowledge-focused Sponsor: Ligue Pulmonaire Genevoise Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether people with active tuberculosis can use a smartphone app to send videos of themselves taking their medication, instead of going to a clinic for direct observation. Researchers enrolled 51 patients in Switzerland and measured how many agreed to use the app and how well it worked. The goal was to see if this approach is practical and acceptable in a low-incidence, high-income setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: video-observed therapy (vDOT) via smartphone app
What this could lead to: If successful, this approach could make it easier and less costly for patients to complete tuberculosis treatment without daily clinic visits.
What could go wrong: This is a small feasibility study (51 participants) in a single region, so results may not apply broadly. Technical issues or patient reluctance could limit adoption.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS ACTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

active tuberculosis Directly Observed Therapy Patient Compliance tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS ACTIVE

Contacts and locations

Locations

Geneva University Hospital

Geneva, Canton of Geneva, 1205, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.